Observational Study on the Efficacy and Safety of NovoSeven® During "Real-life" Usage in Germany
Status:
Completed
Trial end date:
2010-12-01
Target enrollment:
Participant gender:
Summary
This NON INTERVENTIONAL OBSERVATIONAL STUDY is conducted in Europe. The primary aim is to
observe the haemostatic efficacy of NovoSeven® treatment during routine practice in German
clinics. The observational study observes patients with congenital haemophilia with
inhibitors to coagulation factors VIII or IX, acquired haemophilia, congenital FVII
deficiency, or Glanzmann's thrombasthenia who have received at least one dose of NovoSeven®
for treatment of a bleeding episode or for the prevention of a bleeding when undergoing
surgery or an invasive procedure.